首页> 美国卫生研究院文献>Journal of the American Medical Informatics Association : JAMIA >Evaluating the impact of an integrated computer-based decision support with person-centered analytics for the management of asthma in primary care: a randomized controlled trial
【2h】

Evaluating the impact of an integrated computer-based decision support with person-centered analytics for the management of asthma in primary care: a randomized controlled trial

机译:评估基于计算机的集成决策支持与以人为中心的分析方法对基层医疗中哮喘管理的影响:一项随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background Computer-based decision support has been effective in providing alerts for preventive care. Our objective was to determine whether a personalized asthma management computer-based decision support increases the quality of asthma management and reduces the rate of out-of-control episodes.>Methods A cluster-randomized trial was conducted in Quebec, Canada among 81 primary care physicians and 4447 of their asthmatic patients. Patients were followed from the first visit for 3–33 months. The physician control group used the Medical Office of the 21st century (MOXXI) system, an integrated electronic health record. A custom-developed asthma decision support system was integrated within MOXXI and was activated for physicians in the intervention group.>Results At the first visit, 9.8% (intervention) to 12.9% (control) of patients had out-of-control asthma, which was defined as a patient having had an emergency room visit or hospitalization for respiratory-related problems and/or more than 250 doses of fast-acting β-agonist (FABA) dispensed in the past 3 months. By the end of the trial, there was a significant increase in the ratio of doses of inhaled corticosteroid use to fast-acting β-agonist (0.93 vs. 0.69: difference: 0.27; 95% CI: 0.02–0.51; P = 0.03) in the intervention group. The overall out-of-control asthma rate was 54.7 (control) and 46.2 (intervention) per 100 patients per year (100 PY), a non-significant rate difference of −8.7 (95% CI: −24.7, 7.3; P = 0.29). The intervention’s effect was greater for patients with out-of-control asthma at the beginning of the study, a group who accounted for 44.7% of the 5597 out-of-control asthma events during follow-up, as there was a reduction in the event rate of −28.4 per 100 PY (95% CI: −55.6, −1.2; P = 0.04) compared to patients with in-control asthma at the beginning of the study (−0.08 [95% CI: −10.3, 8.6; P = 0.86]).>Discussion This study evaluated the effectiveness of a novel computer-assisted ADS system that facilitates systematic monitoring of asthma control status, follow-up of patients with out of control asthma, and evidence-based, patient-specific treatment recommendations. We found that physicians were more likely to use ADS for out-of-control patients, that in the majority of these patients, they were advised to add an inhaled corticosteroid or a leukotriene inhibitor to the patient s treatment regimen, and the intervention significantly increased the mean ratio of inhaled corticosteroids to FABA during follow-up. It also reduced the rate of out-of-control episodes during follow up among patients whose asthma was out-of-control at the time of study entry. Future research should assess whether coupling patient-specific treatment recommendations, automated follow-up, and home care with comparative feedback on quality and outcomes of care can improve guideline adoption and care outcomes.>Conclusions A primary care-personalized asthma management system reduced the rate of out-of-control asthma episodes among patients whose asthma was poorly controlled at the study’s onset.>Trial Registration Clinicaltrials.gov Identifier: http://clinicaltrials.gov/ct2/show/?term=Asthma&spons=McGill+University&state1=NA%3ACA%3AQC&rank=2
机译:>背景基于计算机的决策支持在提供预防护理警报方面非常有效。我们的目标是确定基于计算机的个性化哮喘管理决策支持是否可以提高哮喘管理质量并降低失控发作率。>方法在魁北克进行了一项集群随机试验,加拿大的81位初级保健医生和4447位哮喘患者。从首次就诊开始对患者进行了3至33个月的随访。医师对照组使用了21世纪医疗办公室(MOXXI)系统,该系统是综合的电子健康记录。定制开发的哮喘决策支持系统已集成到MOXXI中,并被干预组的医生激活。>结果初诊时,有9.8%(干预)至12.9%(对照)的患者-控制性哮喘,定义为在过去3个月内因呼吸系统相关问题而进行急诊就诊或住院和/或分配了250多种速效β激动剂(FABA​​)的患者。到试验结束时,吸入皮质类固醇与速效β受体激动剂的剂量比显着增加(0.93比0.69:差异:0.27; 95%CI:0.02-0.51; P = 0.03)在干预组。每年每100名患者的总体失控哮喘发生率为54.7(对照)和46.2(干预)(100 PY),无显着性差异为-8.7(95%CI:-24.7,7.3; P = 0.29)。在研究开始时,对于哮喘失控患者的干预效果更大,该组在随访期间5597例哮喘失控事件中占44.7%,因为与研究开始时处于对照的哮喘患者相比,每100 PY的事件发生率为-28.4 / 100 PY(95%CI:-55.6,-1.2; P = 0.04)(-0.08 [95%CI:-10.3,8.6; P = 0.86])。>讨论:这项研究评估了新型计算机辅助ADS系统的有效性,该系统有助于系统地监测哮喘控制状态,失控哮喘患者的随访以及证据,基于患者的特定治疗建议。我们发现医师对于失控患者更可能使用ADS,在这些患者中的大多数患者中,建议他们在患者的治疗方案中添加吸入性糖皮质激素或白三烯抑制剂,并且干预措施明显增加随访期间吸入糖皮质激素与FABA的平均比例。它也降低了在研究进入之时哮喘失控的患者在随访期间失控事件的发生率。未来的研究应评估将患者特定的治疗建议,自动随访和家庭护理与对护理质量和结果的比较反馈相结合是否可以改善指南的采用和护理结果。>结论哮喘管理系统降低了研究开始时哮喘控制不佳的患者哮喘失控的发生率。>试验注册 Clinicaltrials.gov标识符:http://clinicaltrials.gov/ct2/ show /?term =哮喘&spons =麦吉尔+大学&state1 = NA%3ACA%3AQC&rank = 2

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号